KDM3B Antikörper (C-Term)
Kurzübersicht für KDM3B Antikörper (C-Term) (ABIN1907639)
Target
Alle KDM3B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Region between residue 1710 and the C-terminus (residue1761) of human Jumonji Domain Containing 1B using the numbering given in entry NP_057688.2 (GeneID 51780).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IF (1:50 - 1:250), IHC, IHC-P (1:100 - 1:500), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Laryngeal Squamous Cell Carcinoma, Ovarian Carcinoma, Prostate Carcinoma. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- KDM3B (Lysine (K)-Specific Demethylase 3B (KDM3B))
-
Andere Bezeichnung
- KDM3B / JMJD1B
-
Hintergrund
-
Name/Gene ID: KDM3B
Synonyms: KDM3B, 5qNCA, C5orf7, JMJD1B, Jumonji domain containing 1B, KIAA1082, Lysine-specific demethylase 3B, NET22, Nuclear protein 5qNCA, JHDM2B -
Gen-ID
- 51780
-
Pathways
- Warburg Effekt
Target
-